Point/Counterpoint: Regenerative Endodontics vs. Apexification

5 (1 vote)

CE Hours: 0

Course Description:

Pulp therapy for children is relatively simple, and quite effective as long as the proper assessment of the situation is made, and treatment is carried out in the appropriate fashion with strict adherence to the proper technique. However, immature teeth with pulp necrosis apical periodontitis present with a compromised prognosis due to short and undeveloped root structures, thin dentinal walls, and wide-open foramens. Although classical apexification remains a treatment option, pulp revascularization exploits the full potential for tissue ingrowth toward dentin-like tissue deposition and stronger roots able to withstand fracture. This presentation will discuss the importance of case selection and review the current evidence-based literature comparing the outcome and predictability of both therapies.    

At the conclusion, participants should be able to:

  • Discuss the challenge of disinfecting immature teeth with necrotic pulps and its impact on ouctome.  
  • Discuss the concept of pulp revascularization for treatment of immature teeth with necrotic pulps.  
  • Develop the most predictable treatment plan for immature teeth with necrotic pulps to obtain a positive outcome.     

     

    

Key:

Complete
Failed
Available
Locked
MP3 Audio
Open to listen to or download MP3 audio.
Open to listen to or download MP3 audio.
Presentation
Open to view video.
Evaluation
7 Questions

Nestor Cohenca, D.D.S., F.I.A.D.T.

Professor

Dr. Nestor Cohenca completed the endodontic program at the Hebrew University in Jerusalem cum laude and received the Best Graduate Student Award. He then served 11 years on faculty at the school while maintaining a private practice limited to endodontics. Dr. Cohenca joined the University of Washington and served as tenured professor of endodontics and pediatric dentistry from 2005-2014. Currently he serves as professor and director of endodontics and the Multidisciplinary Traumatology Unit at Seattle Children’s Hospital and maintains a private practice limited to endodontics in Kirkland, Wash. He is a Diplomate of the Israel Board of Endodontics and the American Board of Endodontics. Dr. Cohenca is a Fellow and past-president of the International Association of Dental Traumatology and received an honorary membership to Omicron Kappa Upsilon National Dental Honor Society. He has published more than 80 peer-reviewed articles, 10 chapters and a book. Dr. Cohenca provided more than 250 lectures around the world and is well known as one of the experts in dental traumatology, endo-pedo-related topics, vital pulp therapy, CBCT and root canal disinfection.

Anibal R. Diogenes, D.D.S., M.S., Ph.D.

Dr. Anibal Diogenes received his D.D.S. from the Federal University o in Brazil, his M.S. in Molecular Biology from the University of Nebraska, and his Ph.D. in Pharmacology and Certificate in Endodontics from the University of Texas Health Science Center at San Antonio. Dr. Diogenes is an associate professor and the director of the endodontic residency program at the University of Texas Health Science Center at San Antonio. His areas of research include pain, neuroscience and regenerative endodontics. He is also an Associate Editor for the Journal of Endodontics and a Diplomate of the American Board of Endodontics.

Anibal Diogenes, D.D.S., M.S., Ph. D. 

Disclosure: In accordance with this policy, I declare that I have NO past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith.

Nestor Cohenca, D.D.S., F.I.A.D.T. 

Disclosure: In accordance with this policy, I declare that I have NO past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith.